skinny
- 22 Apr 2015 14:21
- 36 of 37
Organovo (NYSEMKT:ONVO) enters into a multi-year collaboration agreement with Merck (NYSE:MRK) to develop multiple custom tissue models. The deal includes access to
ONVO's exVive3D Human Liver Tissue service. Financial terms are not disclosed.
ONVO is up 17% premarket on robust volume.
skinny
- 26 May 2015 12:13
- 37 of 37
Gap closure within sight on ATP.